Latest news
Loading news…
Aceragen is a developer of therapeutic treatments intended for rare and ultra-rare diseases.
Aceragen was acquired by Idera Pharmaceuticals in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
2
Monthly Visits
Available in Pro Contacts
10
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Durham, North Carolina, United States
Acquisitions by Aceragen
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Aceragen
Co-Founder, President and CEO
10
professional contacts at Aceragen
Contact execs at Aceragen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Aceragen
Loading news…
FAQs about Aceragen
People who checked this page also checked these
Sectors Aceragen invests & acquires in
Browse the full Acquirezy directory.